{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:02:49Z","timestamp":1790355769098,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T00:00:00Z","timestamp":1276128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00401-010-0707-9","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T06:12:26Z","timestamp":1276063946000},"page":"169-183","source":"Crossref","is-referenced-by-count":86,"title":["Capillary cerebral amyloid angiopathy identifies a distinct APOE \u03b54-associated subtype of sporadic Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"120","author":[{"given":"Dietmar Rudolf","family":"Thal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Papassotiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaomi C.","family":"Saido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Sue T.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Mrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"K\u00f6lsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly Del","family":"Tredici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Attems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estifanos","family":"Ghebremedhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,10]]},"reference":[{"key":"707_CR1","doi-asserted-by":"crossref","DOI":"10.1002\/0471249688","volume-title":"Categorical data analysis","author":"A Agresti","year":"2002","unstructured":"Agresti A (2002) Categorical data analysis, 2nd edn. Wiley, Hoboken","edition":"2"},{"key":"707_CR2","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington DC"},{"key":"707_CR3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00401-003-0796-9","volume":"107","author":"J Attems","year":"2004","unstructured":"Attems J, Jellinger KA (2004) Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology\u2014a pilot study. Acta Neuropathol (Berl) 107:83\u201390","journal-title":"Acta Neuropathol (Berl)"},{"key":"707_CR4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00415-008-0674-4","volume":"255","author":"J Attems","year":"2008","unstructured":"Attems J, Lauda F, Jellinger KA (2008) Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study. J Neurol 255:70\u201376","journal-title":"J Neurol"},{"key":"707_CR5","first-page":"837","volume":"317","author":"C Bancher","year":"1989","unstructured":"Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM (1989) Tau and ubiquitin immunoreactivity at different stages of formation of Alzheimer neurofibrillary tangles. Prog Clin Biol Res 317:837\u2013848","journal-title":"Prog Clin Biol Res"},{"key":"707_CR6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","volume":"118","author":"RD Bell","year":"2009","unstructured":"Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease. Acta Neuropathol 118:103\u2013113","journal-title":"Acta Neuropathol"},{"key":"707_CR7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","volume":"83","author":"L Bertram","year":"2008","unstructured":"Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, Schjeide BM, Hooli B, Divito J, Ionita I, Jiang H, Laird N, Moscarillo T, Ohlsen KL, Elliott K, Wang X, Hu-Lince D, Ryder M, Murphy A, Wagner SL, Blacker D, Becker KD, Tanzi RE (2008) Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE. Am J Hum Genet 83:623\u2013632","journal-title":"Am J Hum Genet"},{"key":"707_CR8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrn2494","volume":"9","author":"L Bertram","year":"2008","unstructured":"Bertram L, Tanzi RE (2008) Thirty years of Alzheimer\u2019s disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9:768\u2013778","journal-title":"Nat Rev Neurosci"},{"key":"707_CR9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF00293315","volume":"87","author":"E Braak","year":"1994","unstructured":"Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554\u2013567","journal-title":"Acta Neuropathol"},{"key":"707_CR10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404","journal-title":"Acta Neuropathol"},{"key":"707_CR11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1750-3639.1991.tb00661.x","volume":"1","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213\u2013216","journal-title":"Brain Pathol"},{"key":"707_CR12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"707_CR13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s007020050096","volume":"105","author":"H Braak","year":"1998","unstructured":"Braak H, Braak E (1998) Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 105:801\u2013819","journal-title":"J Neural Transm"},{"key":"707_CR14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"707_CR15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/NEN.0b013e318177eaf4","volume":"67","author":"RJ Castellani","year":"2008","unstructured":"Castellani RJ, Lee HG, Zhu X, Perry G, Smith MA (2008) Alzheimer disease pathology as a host response. J Neuropathol Exp Neurol 67:523\u2013531","journal-title":"J Neuropathol Exp Neurol"},{"key":"707_CR16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00401-010-0666-1","volume":"119","author":"DZ Christensen","year":"2010","unstructured":"Christensen DZ, Schneider-Axmann T, Lucassen PJ, Bayer TA, Wirths O (2010) Accumulation of intraneuronal Abeta correlates with ApoE4 genotype. Acta Neuropathol 119:555\u2013566","journal-title":"Acta Neuropathol"},{"key":"707_CR17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2990.2004.00614.x","volume":"31","author":"M Christoforidis","year":"2005","unstructured":"Christoforidis M, Schober R, Krohn K (2005) Genetic-morphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 31:11\u201319","journal-title":"Neuropathol Appl Neurobiol"},{"key":"707_CR18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1196\/annals.1297.005","volume":"1019","author":"EH Corder","year":"2004","unstructured":"Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H (2004) The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci 1019:24\u201328","journal-title":"Ann N Y Acad Sci"},{"key":"707_CR19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261:921\u2013923","journal-title":"Science"},{"key":"707_CR20","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, Holtzman DM, Zlokovic BV (2008) apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 118:4002\u20134013","journal-title":"J Clin Invest"},{"key":"707_CR21","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/nm.1868","volume":"14","author":"H Du","year":"2008","unstructured":"Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C, Zhang H, Molkentin JD, Gunn-Moore FJ, Vonsattel JP, Arancio O, Chen JX, Yan SD (2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer\u2019s disease. Nat Med 14:1097\u20131105","journal-title":"Nat Med"},{"key":"707_CR22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(99)02355-7","volume":"354","author":"MM Esiri","year":"1999","unstructured":"Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD (1999) Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer\u2019s disease. Lancet 354:919\u2013920","journal-title":"Lancet"},{"key":"707_CR23","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349\u20131356","journal-title":"JAMA"},{"key":"707_CR24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0165-0270(97)00197-0","volume":"79","author":"E Ghebremedhin","year":"1998","unstructured":"Ghebremedhin E, Braak H, Braak E, Sahm J (1998) Improved method facilitates reliable APOE genotyping of genomic DNA extracted from formaldehyde-fixed pathology specimens. J Neurosci Methods 79:229\u2013231","journal-title":"J Neurosci Methods"},{"key":"707_CR25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1365-2990.2002.00398.x","volume":"28","author":"E Ghebremedhin","year":"2002","unstructured":"Ghebremedhin E, Schultz C, Thal DR, Del Tredici K, Rub U, Braak H (2002) Genetic association of argyrophilic grain disease with polymorphisms in alpha-2 macroglobulin and low-density lipoprotein receptor-related protein genes. Neuropathol Appl Neurobiol 28:308\u2013313","journal-title":"Neuropathol Appl Neurobiol"},{"key":"707_CR26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-3-5","volume":"3","author":"WS Griffin","year":"2006","unstructured":"Griffin WS, Liu L, Li Y, Mrak RE, Barger SW (2006) Interleukin-1 mediates Alzheimer and Lewy body pathologies. J Neuroinflammation 3:5","journal-title":"J Neuroinflammation"},{"key":"707_CR27","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","volume":"86","author":"WS Griffin","year":"1989","unstructured":"Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL 3rd, Araoz C (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86:7611\u20137615","journal-title":"Proc Natl Acad Sci USA"},{"key":"707_CR28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-010-0652-7","volume":"119","author":"LT Grinberg","year":"2010","unstructured":"Grinberg LT, Thal DR (2010) Vascular pathology in the aged human brain. Acta Neuropathol 119:277\u2013290","journal-title":"Acta Neuropathol"},{"key":"707_CR29","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913\u20134917","journal-title":"Proc Natl Acad Sci USA"},{"key":"707_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol 8:101\u2013112","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"Suppl 1","key":"707_CR31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1471-4159.2007.04715.x","volume":"103","author":"T Hartmann","year":"2007","unstructured":"Hartmann T, Kuchenbecker J, Grimm MO (2007) Alzheimer\u2019s disease: the lipid connection. J Neurochem 103(Suppl 1):159\u2013170","journal-title":"J Neurochem"},{"key":"707_CR32","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","volume":"31","author":"JE Hixson","year":"1990","unstructured":"Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545\u2013548","journal-title":"J Lipid Res"},{"key":"707_CR33","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Hughes","year":"1982","unstructured":"Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566\u2013572","journal-title":"Br J Psychiatry"},{"key":"707_CR34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ana.410220110","volume":"22","author":"BT Hyman","year":"1987","unstructured":"Hyman BT, Van Hoesen GW, Damasio AR (1987) Alzheimer\u2019s disease: glutamate depletion in the hippocampal perforant pathway zone. Ann Neurol 22:37\u201340","journal-title":"Ann Neurol"},{"key":"707_CR35","first-page":"872","volume-title":"The human nervous system","author":"R Insausti","year":"2004","unstructured":"Insausti R, Amaral DG (2004) Hippocampal Formation. In: Paxinos G, Mai JK (eds) The human nervous system. Elsevier, London, pp 872\u2013914"},{"key":"707_CR36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1179\/his.1993.16.4.335","volume":"16","author":"K Iqbal","year":"1993","unstructured":"Iqbal K, Braak H, Braak E, Grundke-Iqbal I (1993) Silver labeling of Alzheimer neurofibrillary changes and brain beta-amyloid. J Histotechnol 16:335\u2013342","journal-title":"J Histotechnol"},{"key":"707_CR37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jns.2007.01.045","volume":"257","author":"KA Jellinger","year":"2007","unstructured":"Jellinger KA, Attems J (2007) Neuropathological evaluation of mixed dementia. J Neurol Sci 257:80\u201387","journal-title":"J Neurol Sci"},{"key":"707_CR38","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.neurobiolaging.2006.10.032","volume":"29","author":"KA Josephs","year":"2008","unstructured":"Josephs KA, Whitwell JL, Parisi JE, Knopman DS, Boeve BF, Geda YE, Jack CR Jr, Petersen RC, Dickson DW (2008) Argyrophilic grains: a distinct disease or an additive pathology? Neurobiol Aging 29:566\u2013573","journal-title":"Neurobiol Aging"},{"key":"707_CR39","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI11013","volume":"106","author":"DE Kang","year":"2000","unstructured":"Kang DE, Pietrzik CU, Baum L, Chevallier N, Merriam DE, Kounnas MZ, Wagner SL, Troncoso JC, Kawas CH, Katzman R, Koo EH (2000) Modulation of amyloid beta-protein clearance and Alzheimer\u2019s disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest 106:1159\u20131166","journal-title":"J Clin Invest"},{"key":"707_CR40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/WNL.49.1.56","volume":"49","author":"DE Kang","year":"1997","unstructured":"Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, Hansen LA, Thomas RG, Thal LJ, Katzman R (1997) Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer\u2019s disease. Neurology 49:56\u201361","journal-title":"Neurology"},{"key":"707_CR41","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486\u2013489","journal-title":"Science"},{"key":"707_CR42","first-page":"121","volume":"2","author":"KS Kim","year":"1988","unstructured":"Kim KS, Miller DL, Sapienza VJ, Chen C-MJ, Bai C, Grundke-Iqbal I, Currie JR, Wisniewski HM (1988) Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun 2:121\u2013130","journal-title":"Neurosci Res Commun"},{"key":"707_CR43","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","volume":"10","author":"M Koistinaho","year":"2004","unstructured":"Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, Higgs R, Liu F, Malkani S, Bales KR, Paul SM (2004) Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 10:719\u2013726","journal-title":"Nat Med"},{"key":"707_CR44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eurpsy.2008.12.005","volume":"24","author":"H K\u00f6lsch","year":"2009","unstructured":"K\u00f6lsch H, L\u00fcthjohann D, Jessen F, Popp J, Hentschel F, Kelemen P, Schmitz S, Maier W, Heun R (2009) CYP46A1 variants influence Alzheimer\u2019s disease risk and brain cholesterol metabolism. Eur Psychiatry 24:183\u2013190","journal-title":"Eur Psychiatry"},{"key":"707_CR45","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.mp.4001109","volume":"7","author":"H K\u00f6lsch","year":"2002","unstructured":"K\u00f6lsch H, L\u00fctjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R (2002) Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer\u2019s disease. Mol Psychiatry 7:899\u2013902","journal-title":"Mol Psychiatry"},{"key":"707_CR46","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","volume":"23","author":"Y Li","year":"2003","unstructured":"Li Y, Liu L, Barger SW, Griffin WS (2003) Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci 23:1605\u20131611","journal-title":"J Neurosci"},{"key":"707_CR47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0304-3940(89)90843-4","volume":"107","author":"PL McGeer","year":"1989","unstructured":"McGeer PL, Akiyama H, Itagaki S, McGeer EG (1989) Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 107:341\u2013346","journal-title":"Neurosci Lett"},{"key":"707_CR48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0169-328X(97)00233-7","volume":"52","author":"ID Milton","year":"1997","unstructured":"Milton ID, Banner SJ, Ince PG, Piggott NH, Fray AE, Thatcher N, Horne CH, Shaw PJ (1997) Expression of the glial glutamate transporter EAAT2 in the human CNS: an immunohistochemical study. Brain Res Mol Brain Res 52:17\u201331","journal-title":"Brain Res Mol Brain Res"},{"key":"707_CR49","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"707_CR50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF00353892","volume":"269","author":"SK Moestrup","year":"1992","unstructured":"Moestrup SK, Gliemann J, Pallesen G (1992) Distribution of the alpha 2-macroglobulin receptor\/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 269:375\u2013382","journal-title":"Cell Tissue Res"},{"key":"707_CR51","first-page":"397","volume":"58","author":"JC Morris","year":"2001","unstructured":"Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58:397\u2013405","journal-title":"Arch Neurol"},{"key":"707_CR52","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1046\/j.1471-4159.1997.69051904.x","volume":"69","author":"M Narita","year":"1997","unstructured":"Narita M, Holtzman DM, Schwartz AL, Bu G (1997) Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J Neurochem 69:1904\u20131911","journal-title":"J Neurochem"},{"key":"707_CR53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","volume":"43","author":"S Oddo","year":"2004","unstructured":"Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM (2004) Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43:321\u2013332","journal-title":"Neuron"},{"key":"707_CR54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000090362","volume":"2","author":"A Papassotiropoulos","year":"2005","unstructured":"Papassotiropoulos A, Lambert JC, Wavrant-De Vrieze F, Wollmer MA, von der Kammer H, Streffer JR, Maddalena A, Huynh KD, Wolleb S, L\u00fctjohann D, Schneider B, Thal DR, Grimaldi LM, Tsolaki M, Kapaki E, Ravid R, Konietzko U, Hegi T, Pasch T, Jung H, Braak H, Amouyel P, Rogaev EI, Hardy J, Hock C, Nitsch RM (2005) Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer\u2019s disease. Neurodegener Dis 2:233\u2013241","journal-title":"Neurodegener Dis"},{"key":"707_CR55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneur.60.1.29","volume":"60","author":"A Papassotiropoulos","year":"2003","unstructured":"Papassotiropoulos A, Streffer JR, Tsolaki M, Schmid S, Thal D, Nicosia F, Iakovidou V, Maddalena A, L\u00fctjohann D, Ghebremedhin E, Hegi T, Pasch T, Traxler M, Bruhl A, Benussi L, Binetti G, Braak H, Nitsch RM, Hock C (2003) Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol 60:29\u201335","journal-title":"Arch Neurol"},{"key":"707_CR56","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1582-4934.2007.00054.x","volume":"11","author":"PC Reid","year":"2007","unstructured":"Reid PC, Urano Y, Kodama T, Hamakubo T (2007) Alzheimer\u2019s disease: cholesterol, membrane rafts, isoprenoids and statins. J Cell Mol Med 11:383\u2013392","journal-title":"J Cell Mol Med"},{"key":"707_CR57","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.90.22.10836","volume":"90","author":"AE Roher","year":"1993","unstructured":"Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, Ball MJ (1993) beta-Amyloid-(1\u201342) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 90:10836\u201310840","journal-title":"Proc Natl Acad Sci USA"},{"key":"707_CR58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0896-6273(95)90301-1","volume":"14","author":"TC Saido","year":"1995","unstructured":"Saido TC, Iwatsubo T, Mann DM, Shimada H, Ihara Y, Kawashima S (1995) Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques. Neuron 14:457\u2013466","journal-title":"Neuron"},{"key":"707_CR59","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","volume":"73","author":"S Salloway","year":"2009","unstructured":"Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, Sabbagh M, Honig LS, Doody R, van Dyck CH, Mulnard R, Barakos J, Gregg KM, Liu E, Lieberburg I, Schenk D, Black R, Grundman M (2009) A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 73:2061\u20132070","journal-title":"Neurology"},{"key":"707_CR60","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/00001756-200105250-00014","volume":"12","author":"S Sasaki","year":"2001","unstructured":"Sasaki S, Warita H, Abe K, Komori T, Iwata M (2001) EAAT1 and EAAT2 immunoreactivity in transgenic mice with a G93A mutant SOD1 gene. Neuroreport 12:1359\u20131362","journal-title":"Neuroreport"},{"key":"707_CR61","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0304-3940(92)90104-F","volume":"140","author":"PE Sautiere","year":"1992","unstructured":"Sautiere PE, Sindou P, Couratier P, Hugon J, Wattez A, Delacourte A (1992) Tau antigenic changes induced by glutamate in rat primary culture model: a biochemical approach. Neurosci Lett 140:206\u2013210","journal-title":"Neurosci Lett"},{"key":"707_CR62","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977\u20131981","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"707_CR63","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.neurobiolaging.2008.07.021","volume":"31","author":"RH Takahashi","year":"2008","unstructured":"Takahashi RH, Capetillo-Zarate E, Lin MT, Milner TA, Gouras GK (2008) Co-occurrence of Alzheimer\u2019s disease beta-amyloid and tau pathologies at synapses. Neurobiol Aging 31(7):1145\u20131152","journal-title":"Neurobiol Aging"},{"key":"707_CR64","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00005072-199801000-00009","volume":"57","author":"TL Tekirian","year":"1998","unstructured":"Tekirian TL, Saido TC, Markesbery WR, Russell MJ, Wekstein DR, Patel E, Geddes JW (1998) N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits. J Neuropathol Exp Neurol 57:76\u201394","journal-title":"J Neuropathol Exp Neurol"},{"key":"707_CR65","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1750-3639.2002.tb00457.x","volume":"12","author":"DR Thal","year":"2002","unstructured":"Thal DR (2002) Excitatory amino acid transporter EAAT-2 in tangle-bearing neurons in Alzheimer\u2019s disease. Brain Pathol 12:405\u2013411","journal-title":"Brain Pathol"},{"key":"707_CR66","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.neurobiolaging.2008.01.017","volume":"30","author":"DR Thal","year":"2009","unstructured":"Thal DR, Capetillo-Zarate E, Larionov S, Staufenbiel M, Zurbruegg S, Beckmann N (2009) Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances. Neurobiol Aging 30:1936\u20131948","journal-title":"Neurobiol Aging"},{"key":"707_CR67","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/jnen\/62.12.1287","volume":"62","author":"DR Thal","year":"2003","unstructured":"Thal DR, Ghebremedhin E, Orantes M, Wiestler OD (2003) Vascular pathology in Alzheimer\u2019s disease: correlation of cerebral amyloid angiopathy and arteriosclerosis\/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 62:1287\u20131301","journal-title":"J Neuropathol Exp Neurol"},{"key":"707_CR68","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","volume":"61","author":"DR Thal","year":"2002","unstructured":"Thal DR, Ghebremedhin E, R\u00fcb U, Yamaguchi H, Del Tredici K, Braak H (2002) Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61:282\u2013293","journal-title":"J Neuropathol Exp Neurol"},{"key":"707_CR69","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","volume":"115","author":"DR Thal","year":"2008","unstructured":"Thal DR, Griffin WST, De Vos RAI, Ghebremedhin E (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer\u2019s disease. Acta Neuropathol 115:599\u2013609","journal-title":"Acta Neuropathol"},{"key":"707_CR70","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.neurobiolaging.2006.05.029","volume":"28","author":"DR Thal","year":"2007","unstructured":"Thal DR, Larionov S, Abramowski D, Wiederhold KH, Van Dooren T, Yamaguchi H, Haass C, Van Leuven F, Staufenbiel M, Capetillo-Zarate E (2007) Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice. Neurobiol Aging 28:1221\u20131230","journal-title":"Neurobiol Aging"},{"key":"707_CR71","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of Abeta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"707_CR72","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/jnen\/59.8.733","volume":"59","author":"DR Thal","year":"2000","unstructured":"Thal DR, R\u00fcb U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K, Braak E, Braak H (2000) Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59:733\u2013748","journal-title":"J Neuropathol Exp Neurol"},{"key":"707_CR73","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00005072-199902000-00010","volume":"58","author":"DR Thal","year":"1999","unstructured":"Thal DR, Sassin I, Schultz C, Haass C, Braak E, Braak H (1999) Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of Abeta. J Neuropathol Exp Neurol 58:210\u2013216","journal-title":"J Neuropathol Exp Neurol"},{"key":"707_CR74","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2990.2005.00635.x","volume":"31","author":"DR Thal","year":"2005","unstructured":"Thal DR, Schultz C, Botez G, Del Tredici K, Mrak RE, Griffin WS, Wiestler OD, Braak H, Ghebremedhin E (2005) The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer\u2019s disease-related pathology. Neuropathol Appl Neurobiol 31:270\u2013279","journal-title":"Neuropathol Appl Neurobiol"},{"key":"707_CR75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/archneurol.2009.913","volume":"67","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty M, Beason-Held L, An Y, Kraut MA, Resnick SM (2010) APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch Neurol 67:93\u201398","journal-title":"Arch Neurol"},{"key":"707_CR76","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0197-4580(97)00057-2","volume":"18","author":"The National Institute on Aging","year":"1997","unstructured":"The National Institute on Aging (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer\u2019s disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer\u2019s Disease. Neurobiol Aging 18:S1\u2013S2","journal-title":"Neurobiol Aging"},{"key":"707_CR77","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1471-4159.2010.06661.x","volume":"113","author":"G Tian","year":"2010","unstructured":"Tian G, Kong Q, Lai L, Ray-Chaudhury A, Lin CL (2010) Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer\u2019s disease. J Neurochem 113:978\u2013989","journal-title":"J Neurochem"},{"key":"707_CR78","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/NEN.0b013e3181836a71","volume":"67","author":"S Utter","year":"2008","unstructured":"Utter S, Tamboli IY, Walter J, Rijal Upadhaya A, Birkenmeier G, Pietrzik CU, Ghebremedhin E, Thal DR (2008) Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes. J Neuropathol Exp Neurol 67:842\u2013856","journal-title":"J Neuropathol Exp Neurol"},{"key":"707_CR79","doi-asserted-by":"crossref","first-page":"19318","DOI":"10.1073\/pnas.0804871105","volume":"105","author":"X Wang","year":"2008","unstructured":"Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins. Proc Natl Acad Sci USA 105:19318\u201319323","journal-title":"Proc Natl Acad Sci USA"},{"key":"707_CR80","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1021\/pr7006076","volume":"7","author":"Y Wang","year":"2008","unstructured":"Wang Y, Muneton S, Sjovall J, Jovanovic JN, Griffiths WJ (2008) The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome. J Proteome Res 7:1606\u20131614","journal-title":"J Proteome Res"},{"key":"707_CR81","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00005072-199810000-00001","volume":"57","author":"RO Weller","year":"1998","unstructured":"Weller RO (1998) Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J Neuropathol Exp Neurol 57:885\u2013894","journal-title":"J Neuropathol Exp Neurol"},{"key":"707_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0457-0","volume":"117","author":"RO Weller","year":"2009","unstructured":"Weller RO, Djuanda E, Yow HY, Carare RO (2009) Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 117:1\u201314","journal-title":"Acta Neuropathol"},{"key":"707_CR83","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0002-9440(10)65616-7","volume":"153","author":"RO Weller","year":"1998","unstructured":"Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE (1998) Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer\u2019s disease. Am J Pathol 153:725\u2013733","journal-title":"Am J Pathol"},{"key":"707_CR84","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.neuroscience.2009.01.023","volume":"159","author":"DM Wilcock","year":"2009","unstructured":"Wilcock DM, Vitek MP, Colton CA (2009) Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer\u2019s disease. Neuroscience 159:1055\u20131069","journal-title":"Neuroscience"},{"key":"707_CR85","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.2218531","volume":"250","author":"BA Yankner","year":"1990","unstructured":"Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250:279\u2013282","journal-title":"Science"},{"key":"707_CR86","doi-asserted-by":"crossref","first-page":"27273","DOI":"10.1074\/jbc.M109.014464","volume":"284","author":"N Zhong","year":"2009","unstructured":"Zhong N, Ramaswamy G, Weisgraber KH (2009) Apolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function. J Biol Chem 284:27273\u201327280","journal-title":"J Biol Chem"},{"key":"707_CR87","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jalz.2008.01.006","volume":"4","author":"N Zhong","year":"2008","unstructured":"Zhong N, Scearce-Levie K, Ramaswamy G, Weisgraber KH (2008) Apolipoprotein E4 domain interaction: synaptic and cognitive deficits in mice. Alzheimers Dement 4:179\u2013192","journal-title":"Alzheimers Dement"},{"key":"707_CR88","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178\u2013201","journal-title":"Neuron"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-010-0707-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-010-0707-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-010-0707-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T23:47:57Z","timestamp":1635464877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-010-0707-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,10]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["707"],"URL":"https:\/\/doi.org\/10.1007\/s00401-010-0707-9","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,10]]}}}